These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37378759)

  • 41. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.
    Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN
    Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves.
    Lee BR; Harrison CJ; Myers AL; Jackson MA; Selvarangan R
    J Clin Virol; 2022 Sep; 154():105220. PubMed ID: 35810686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of within-host genetic diversity in SARS-CoV-2.
    Tonkin-Hill G; Martincorena I; Amato R; Lawson ARJ; Gerstung M; Johnston I; Jackson DK; Park N; Lensing SV; Quail MA; Gonçalves S; Ariani C; Spencer Chapman M; Hamilton WL; Meredith LW; Hall G; Jahun AS; Chaudhry Y; Hosmillo M; Pinckert ML; Georgana I; Yakovleva A; Caller LG; Caddy SL; Feltwell T; Khokhar FA; Houldcroft CJ; Curran MD; Parmar S; ; Alderton A; Nelson R; Harrison EM; Sillitoe J; Bentley SD; Barrett JC; Torok ME; Goodfellow IG; Langford C; Kwiatkowski D;
    Elife; 2021 Aug; 10():. PubMed ID: 34387545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omicron variant as nature's solution to the COVID-19 pandemic.
    Li Wan Po A
    J Clin Pharm Ther; 2022 Jan; 47(1):3-5. PubMed ID: 35128705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccines against SARS-CoV-2 variants and future pandemics.
    Park T; Hwang H; Moon S; Kang SG; Song S; Kim YH; Kim H; Ko EJ; Yoon SD; Kang SM; Hwang HS
    Expert Rev Vaccines; 2022 Oct; 21(10):1363-1376. PubMed ID: 35924678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic].
    Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö
    Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
    Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
    PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19: Vaccines and therapeutics.
    Ponnampalli S; Venkata Suryanarayana Birudukota N; Kamal A
    Bioorg Med Chem Lett; 2022 Nov; 75():128987. PubMed ID: 36113669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The reproduction rate of severe acute respiratory syndrome coronavirus 2 different variants recently circulated in human: a narrative review.
    Karimizadeh Z; Dowran R; Mokhtari-Azad T; Shafiei-Jandaghi NZ
    Eur J Med Res; 2023 Feb; 28(1):94. PubMed ID: 36823532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.
    Chadha J; Khullar L; Mittal N
    Environ Microbiol; 2022 Jun; 24(6):2615-2629. PubMed ID: 34320263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
    Ren B; Liao BY; Wang JN; Peng X; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simulation study reveals factors that affect the predominance of SARS-CoV-2 novel variant.
    Furuse Y
    Virol J; 2021 Dec; 18(1):253. PubMed ID: 34930336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wastewater monitoring for detection of public health markers during the COVID-19 pandemic: Near-source monitoring of schools in England over an academic year.
    Hassard F; Vu M; Rahimzadeh S; Castro-Gutierrez V; Stanton I; Burczynska B; Wildeboer D; Baio G; Brown MR; Garelick H; Hofman J; Kasprzyk-Hordern B; Majeed A; Priest S; Denise H; Khalifa M; Bassano I; Wade MJ; Grimsley J; Lundy L; Singer AC; Di Cesare M
    PLoS One; 2023; 18(5):e0286259. PubMed ID: 37252922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The global epidemic of SARS-CoV-2 variants and their mutational immune escape.
    Tian D; Sun Y; Zhou J; Ye Q
    J Med Virol; 2022 Mar; 94(3):847-857. PubMed ID: 34609003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
    Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
    Front Immunol; 2021; 12():809244. PubMed ID: 35046961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.
    Sharun K; Tiwari R; Dhama K; Emran TB; Rabaan AA; Al Mutair A
    Hum Vaccin Immunother; 2021 Oct; 17(10):3491-3494. PubMed ID: 34161189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.